FDA Clears Medtronic’s CRRT System For Pediatric Kidney Disease
The de novo clearance makes the Carpediem system the first commercially available system indicated for continuous renal replacement therapy in pediatric patients.
You may also be interested in...
The pandemic may accelerate a move toward versatile, single-solution renal replacement therapy in intensive care.
Medtronic PLC is expanding its presence in the end-stage renal disease device market with the acquisition of hemodialysis company Bellco Health Corp.
The $250m deal adds A&E Medical’s sternal sutures, cable systems, and rigid fixation systems to Zimmer Biomet’s Dental, Spine & Craniomaxillofacial and Thoracic business.